TMO Thermo Fisher Scientific
Health Care · S&P 500
Next earnings: Thu 28 Jan 2027 · estimated
What 30 analyst firms say about Thermo Fisher Scientific: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
31 rated views · 32 analyst/firm records · 30 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8052
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8071
Recent analyst activity · last 90 days
Our tracked history has 33 reports on TMO from 25 analyst firms in the last 90 days (30 firms in the past year).
Comparing each firm's latest target with its previous one: 11 raised their price target, 2 left it unchanged and 3 have their first observed target in the past year.
Ratings, latest available report against the previous one: 2 upgrades and 3 downgrades.
Latest observed target change: Argus Research raised its target from $560.00 (set 27 Jul 2026) to $780.00 on 30 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | David Toung | Buy | 30 Oct 2026 | 780.00 USD |
| Baird | Catherine Schulte | Buy | 22 Oct 2026 | 756.00 USD |
| Barclays | Luke Sergott | Buy | 22 Oct 2026 | 775.00 USD |
| Bernstein | Eve Burstein | Hold | 26 Sep 2026 | Conflicting reports · excluded |
| BMO Capital Markets | Unnamed analyst | Hold | 9 Sep 2026 | — |
| Citigroup | Joanne K Wuensch | Buy | 23 Oct 2026 | 800.00 USD |
| Citigroup | Patrick Donnelly | Buy | 23 Oct 2026 | 800.00 USD |
| CLSA | Michael Luo | Buy | 3 Sep 2026 | 748.00 USD |
| Deutsche Bank | Unnamed analyst | Buy | 25 Sep 2026 | 720.00 USD |
| DZ Bank | Aristotelis Moutopoulos | Hold | 23 Oct 2026 | Conflicting reports · excluded |
| Erste Group | Hans Engel | Hold | 18 Sep 2026 | — |
| Evercore ISI | Vijay Kumar | Buy | 7 Oct 2026 | Conflicting reports · excluded |
| Goldman Sachs | Evie Koslosky | Buy | 24 Jul 2026 | Conflicting reports · excluded |
| Guggenheim | Subbu Nambi | Buy | 15 Oct 2026 | 740.00 USD |
| HSBC | Rajesh Kumar | Buy | 1 Sep 2026 | 690.00 USD |
| HSBC | Sidharth Sahoo | Buy | 1 Sep 2026 | — |
| Jefferies | Tycho W Peterson | Buy | 22 Oct 2026 | 785.00 USD |
| KeyBanc Capital Markets | Paul Knight | Buy | 26 May 2026 | 750.00 USD |
| Leerink Partners | Puneet Souda | Buy | 23 Jul 2026 | 620.00 USD |
| Morgan Stanley | Tejas Savant | Buy | 12 Oct 2026 | 730.00 USD |
| Piper Sandler | David M Westenberg | Hold | 21 Oct 2026 | 600.00 USD · 9 Sep 2026 |
| RBC Capital Markets | Dan Leonard | Hold | 22 Oct 2026 | 730.00 USD |
| Redburn | Ed Ridley-Day | Buy | 24 Jul 2026 | Conflicting reports · excluded |
| Scotiabank | Unnamed analyst | Buy | 9 Sep 2026 | — |
| Stifel | Daniel Arias | Buy | 22 Oct 2026 | 775.00 USD |
| TD Cowen | Dan Brennan | Buy | 22 Oct 2026 | 810.00 USD |
| UBS | Doug Schenkel | Buy | 22 Oct 2026 | 800.00 USD |
| Weiss Ratings | Unnamed analyst | — | 8 Oct 2026 | — |
| Wells Fargo | Brandon Couillard | Sell | 9 Sep 2026 | — |
| William Blair | Matt Larew | Buy | 22 Oct 2026 | — |
| Wolfe Research | Mike Polark | Buy | 22 Oct 2026 | 750.00 USD |
| Data feed RESEARCH | Research Team | Hold | 8 May 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:03 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.